Comparing two plasma p-tau217 assays for Alzheimer’s detection and monitoring

Researchers compared two commercially available blood tests based on the biomarker p-tau217 for diagnosing Alzheimer’s disease in 294 patients. Both tests demonstrated robust diagnostic capabilities, strongly correlating with established Alzheimer’s biomarkers from PET scans.